2
Total investments
0
Early stage
0
Mid stage
1
Late stage
10y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Dec 2021
Huma is a global healthcare AI company on a mission to accelerate the adoption of digital solutions in care and research.
Huma’s technology has powered over 3,000 hospitals and clinics, with 500+ unique deployments across 70+ countries. The software has been used to engage and screen over 35 million individuals, with 1.8 million active users across its various products. The company is renowned for its role in major national healthcare projects worldwide, from the US and the UK to Germany, Greece, and Saudi Arabia, as well as working with most large pharma companies and CROs.
The Huma Cloud Platform offers a technology infrastructure built on strong regulatory foundations to launch digital solutions for healthcare and research. Huma has achieved FDA 510(k) Class II, EU/MDR Class IIb, and Saudi FDA Class C regulatory clearance for its disease-agnostic flagship product, enabling rapid, code-free configuration with the ability to host AI/ML models.
Experience · 7 entries
All (7)
Investments (2)
Board (1)
2026
Associate
Jan 2026
Pavilion is the world’s #1 private community for go-to-market leaders in B2B tech to connect, learn, and grow.
With 10,000 members and counting, you’ll have access to an exclusive Slack community, local and global events, comprehensive courses through Pavilion University, and over 1,300 resources in our curated knowledge hub.
Visit joinpavilion.com to learn more and become a member today.
2024
Associate Vice President of Sales
Jun 2024
Augnito is a leading voice recognition software built with the goal to improve the quality of clinical documentation while allowing doctors to be more efficient by the use of cutting edge technology.
2023
Business Development and Partnerships Director
Sep 2023
At Caresyntax, we are dedicated to making surgery safer and smarter. Our mission is to converge AI-powered software, devices, and clinical services to help our customers improve surgical outcomes. Our platform, an enterprise-grade surgical intelligence system, is vendor-neutral and equipped with proprietary software, hardware, and advanced AI capabilities. It can ingest and analyze data throughout the surgical workflow, including EMR, video, audio, image, device data, financial and outcomes data, and clinical and operational metrics to capture a complete picture of the surgical pathway.
The platform generates insights across the entire continuum of care—before the procedure with surgical workflow optimization, during surgery with real-time clinically relevant support tools, and post procedure with clinical safety modules. The platform also produces data analytics and insights for medical device companies, insurers, and other ecosystem players to innovate and drive the future of healthcare delivery.
Headquartered in the US in San Francisco and internationally in Berlin, Caresyntax software is used in over 4,200 ORs globally and aids surgical teams in over 3 million procedures annually.
To learn more about how we’re transforming surgical care, visit us at www.caresyntax.com.
2022
Director Of Partnerships
Jan 2022
Okadoc is a one-stop-shop patient engagement platform based in the UAE that helps providers seamlessly connect with their patients. Founded in 2018, Okadoc operates across 3 countries including UAE, KSA and Indonesia. Okadoc enables health systems to offer a wide range of services from 24/7 self-scheduling and telehealth to marketplace and payments.
For health systems and plans, Okadoc is a technology partner that increases operational efficiency and improves patient engagement and retention. For patients, it’s an all-in-one platform that digitizes the patient experience and provides access to quality care, resulting in better health outcomes.
Our white-labeled solution is trusted by the region’s leading healthcare and payor groups As the best-funded healthtech startup in the GCC, Okadoc aims to improve the healthcare experience for all.
2021
Investor
Dec 2021
Huma is a global healthcare AI company on a mission to accelerate the adoption of digital solutions in care and research.
Huma’s technology has powered over 3,000 hospitals and clinics, with 500+ unique deployments across 70+ countries. The software has been used to engage and screen over 35 million individuals, with 1.8 million active users across its various products. The company is renowned for its role in major national healthcare projects worldwide, from the US and the UK to Germany, Greece, and Saudi Arabia, as well as working with most large pharma companies and CROs.
The Huma Cloud Platform offers a technology infrastructure built on strong regulatory foundations to launch digital solutions for healthcare and research. Huma has achieved FDA 510(k) Class II, EU/MDR Class IIb, and Saudi FDA Class C regulatory clearance for its disease-agnostic flagship product, enabling rapid, code-free configuration with the ability to host AI/ML models.
Show all 7 entries ↓
Similar investors
Software investors in United Arab Emirates
Investor lists
Lists that match Hamza's portfolio
- Software investors in United Arab Emirates193 investors






